Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-04

Clinical Trial Update: Intrapartum Glycemic Control in GDMA2 [NA]

View source ↗

Summary

The trial examining intrapartum glycemic control in pregnancies affected by gestational diabetes mellitus (GDMA2) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Inova Health Care Services | Conditions: Pregnancy, Gestational Diabetes Mellitus, Class A2 | NA | Status: TERMINATED